A. Perrier (Geneva, Switzerland), G. Meyer (Paris, France)
Risk factors and clinical significance of residual perfusion defects after symptomatic pulmonary embolism (PE)
A. Roux, D. Wermert, D. Helley, A. M. Fischer, H. Sors, G. Meyer, O. Sanchez (Paris, France)
|   |
Fibrinogen AaThr312Ala polymorphism predisposes to chronic thromboembolic pulmonary hypertension
J. Suntharalingam, K. Goldsmith, V. van Marion, F. Dudbridge, M. Toshner, J. Pepke-Zaba, J. Eikenboom, N. Morrell (Papworth Everard, Cambridge, United Kingdom; Leiden, Netherlands)
| |
Initial results of the UK audit of chronic thromboembolic pulmonary hypertension (CTEPH)
R. Condliffe, D. G. Kiely, J. S. R. Gibbs, P. A. Corris, A. Peacock, D. Jenkins, D. Hodgkins, I. Armstrong, C. Torpy, R. Crackett, C. Carlin, C. Das, G. Coghlan, J. Pepke-Zaba (Cambridge, Sheffield, London, Newcastle-upon-Tyne, Glasgow, United Kingdom)
| |
Gender differences in chronic thromboembolic pulmonary hypertension in Japan
A. Shigeta, N. Tanabe, H. Shimizu, S. Toyama, M. Maruoka, J. Terada, S. Hoshino, S. Sakao, Y. Kasahara, Y. Tada, Y. Takiguchi, K. Tatsumi, H. Matsubara, M. Masuda, T. Kuriyama (Chiba, Japan)
|  |
Treatment of VTE during pregnancy with a once-daily regimen of LMWH
F. Parent, F. Jilwan, A. Hamid, X. Jaïs, O. Sanchez, G. Simonneau (Clamart, Paris, France)
| |
Myocarditis of the right and left ventricle following acute pulmonary embolism
M. L. Handoko, J. W. M. Niessen, I. Schalij, W. J. Paulus, A. Paulus (Amsterdam, Netherlands)
| |
Overexpression of pro-apoptotic factors and endothelial cell death in chronically obstructed and reperfused pulmonary artery
E. Sage, E. Fadel, F. Vanden Eyden, O. Mercier, S. Eddahibi, P. Dartevelle (Le Plessis Robinson, France)
| |